Synthesis and in vivo distribution in the rat of several fluorine-18 labeled N-fluoroalkylaporphines

Atkinson, 1975, Emetic activity of N-substituted norapomorphines, J. Med. Chem., 18, 1000, 10.1021/jm00244a010 Baldessarini, 1991, R(−)2-fluoro-N-n-propylnorapomorphine: a very potent and D2-selective dopamine agonist, Neuropharmacology, 30, 97, 10.1016/0028-3908(91)90049-H Berridge, 1985, Aromatic fluorination with n.c.a. 18F-fluoride: a comparative study, J. Label. Comps Radiopharm., 22, 687, 10.1002/jlcr.2580220708 Campbell, 1986, Behavioral effects of apomorphine isomers in the rat: Selective locomotor-inhibitory effects of S(+)N-n-propylnorapomorphine, Psychopharmacology, 88, 158, 10.1007/BF00652233 Gao, 1990, Synthesis and dopamine receptor affinities of enantiomers of 2-substituted apomorphines and their N-n-propyl analogues, J. Med. Chem., 33, 1800, 10.1021/jm00168a040 Granchelli, 1980, Aporphines 27. Mechanistic aspects of the rearrangement of thebaine and codeine analogues in methane-sulfonic acid. Improved method for synthesis of N-alkylated aporphines, J. Org. Chem., 45, 2275, 10.1021/jo01300a001 Kaiser, 1985, Dopamine receptors: functions, subtypes and emerging concepts, Med. Res., 5, 145, 10.1002/med.2610050202 Knöchel, 1991, Aromatic n.c.a. labelling with 18F− by modified Balz-Schiemann decomposition, Int. J. Appl. Radiat. Isot., 42, 1077, 10.1016/0883-2889(91)90014-R Korf, 1978, Rapid decarboxylation of carbon-11 labelled DL-DOPA in the brain: a potential approach for external detection of nervous structures, Brain Res., 145, 59, 10.1016/0006-8993(78)90796-5 Miller, 1988, Trends Pharmac. Sci., 9, 282, 10.1016/0165-6147(88)90011-9 Neumeyer, 1980, Aporphines 30. (−)-N-(2-chloroethyl)-10,11-dihydroxynorapomorphine (chloroethylnorapomorphine), a novel irreversible dopamine receptor antagonist, J. Med. Chem., 23, 594, 10.1021/jm00180a002 Neumeyer, 1981, Aporphines 34. (−)-2,10,11-trihydroxy-N-n-propylnoraporphine, a novel dopaminergic aporphine alkaloid with anticonvulsant activity, J. Med. Chem., 24, 898, 10.1021/jm00139a027 Neumeyer, 1981, Aporphines 36. Dopamine receptor interactions of trihydroxyaporphines. Synthesis, radioreceptor binding, and striatal adenylate cyclase stimulation of 2,10,11-trihydroxyaporphines in comparison with other hydroxylated aporphines, J. Med. Chem., 24, 1440, 10.1021/jm00144a014 Pohland A. and Sullivan H.R. (1967) U.S. Pat. 3342824 Ramsby, 1989, 2-Haloaporphines as potent dopamine agonists, J. Med. Chem., 32, 1198, 10.1021/jm00126a009 Rice, 1975, An improved procedure for the N-demethylation of 6,7-benzomorphans, morphine, and codeine, J. Org. Chem., 40, 1850, 10.1021/jo00900a044 Riffee, 1982, Inhibition of R-(−)-apomorphine-induced stereotypic cage-climbing behavior in mice by S-(+)-apomorphine, 37, 357 Seeman, 1981, Brain dopamine receptors, Pharmac. Rev., 32, 230 Siegel, 1956 Sokoloff, 1990, Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics, Nature, 347, 146, 10.1038/347146a0 Van der Werf, 1984, Synthesis and in vivo distribution in rat brain of 11C-labelled N-alkylated ADTN derivatives, Int. J. Appl. Radiat. Isot., 35, 377, 10.1016/0020-708X(84)90045-0 Van der Werf, 1984, In vivo binding of N-n-propylnorapomorphine in the rat striatum: quantification after lesions produced by kainate, 6-hydroxy-dopamine and decorticatio, Eur J. Pharmac., 102, 251, 10.1016/0014-2999(84)90256-5 Van Schaik, 1983, Pulmonary extractions of dopamine in the conscious dog, Arch. Int. Physiol. Biochim., 91, 215 Welch, 1988, N-3-[18F]fluoropropyl)-spiperone: the preferred 18F labeled spiperone analog for Positron Emission Tomographic studies of the dopamine receptor, Nucl. Med. Biol., 15, 83 Zijlstra, 1993, Synthesis and in vivo distribution in the rat of a dopamine agonist: N-([11C]-methyl)norapomorphine, Nucl. Med. Biol., 10.1016/0969-8051(93)90131-D